Sustained immunological responses to highly active antiretroviral therapy at 36 months in a ghanaian HIV cohort

Clinical Infectious Diseases

Volumn 48, Issue 7, 2009, Pages 988-991

  Collini, Paul ^a,e,f   Schwab, Uli ^b,e,f   Sarfo, Stephen ^e,f   Obeng Baah, Joseph ^e,f   Norman, Betty ^e,f   Chadwick, David ^c   Bibby, David ^d   Bedu Addo, George ^e,f  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^c JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^d ROYAL LONDON HOSPITAL   (United Kingdom)

^e KOMFO ANOKYE TEACHING HOSPITAL   (Ghana)

^f KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT FAILURE; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; GHANA; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 63649107860     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/597353     Document Type: Article

References (12)

1. Ghana Health Service. HIV sentinel survey report 2003. Accra, Ghana: National AIDS Control Pro gramme, Ghana Health Service, 2003.
2. Lawn SD, Myer L, Bekker LG, Wood R. CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa. BMC Infect Dis 2006; 6:59.
3. Hoffmann CJ, Fielding KL, Charalambous S, et al. Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events. AIDS 2008; 22:67-74.
4. Phillips AN, Pillay D, Miners AH, Bennett DE, Gilks CF, Lundgren JD. Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model. Lancet 2008; 371:1443-51.
5. Hosseinipour M, van Oosterhout J, Weigel R, et al. Validating clinical and immunological definitions of antiretroviral treatment failure in Malawi [abstract WEAB101]. In: Program and abstracts of the 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (Sydney, Australia). Stockholm: International AIDS Society, 2007.
6. Basenero A, Castelnuovo B, Birabwe E, et al. Inadequacy of clinical and immunological criteria in identifying virologic failure of 1st line ART: the Ugandan experience [abstract WEAB102]. In: Program and abstracts of the 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (Sydney, Australia). Stockholm: International AIDS Society, 2007.
7. Ghana Health Service. Guidelines for the use of antiretroviral therapy. Accra, Ghana: National AIDS Control Programme, Ghana Health Service, 2003.
8. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach, 2006 revision. Geneva: World Health Organization, 2006.
9. May M, Sterne JA, Sab in C, et al. Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. AIDS 2007; 21:1185-97.
10. Bagchi S, Kempf MC, Westfall AO, Maherya A, Willig J, Saag MS. Can routine clinical markers be used longitudinally to monitor antiretroviral therapy success in resource-limited settings? Clin Infect Dis 2007; 44:135-8.
11. Coutinho A, Mermin J, Ekwaru J, et al. Utility of routine viral load, CD4 cell count, and clinical monitoring among HIV-infected adults in Uganda: a randomized trial [abstract 125]. In: Program and abstracts of the 15th Conference on Retroviruses and Opportunistic Infections (Boston). Alexandria, VA: Foundation for Retrovirology and Human Health, 2008.
12. Yu JK, Chen SC, Wang KY, et al. True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi. Bull World Health Organ 2007; 85:550-4.